GGrantIndex
← Search

Allergen and T-Cell Reagent Resources for the Study of Allergic Diseases

$2,189,410N01FY2011AINIH

Benaroya Research Inst At Virginia Mason, Seattle WA

Investigators

Abstract

This contract supports two distinct objectives. The first objective is to support core facilities that will use innovative isolation and purification techniques to identify novel allergens associated with allergic diseases including asthma and allergic rhinitis, from various sources. The second objective is to identify and characterize peptides containing T cell epitopes that induce anergy in allergen-specific effector T cells, or activate allergen-specific regulatory T cells. The major goals of this initiative are to identify novel allergens using innovative purification methods, and to generate a set of defined peptides that regulate the function of allergen-specific effector and regulatory T cells.

View original record on NIH RePORTER →